Matrix Metalloproteinases and their Inhibitors in Hypertensive Cardiac Remodelling

Author： Marchesi Chiara   Maresca Andrea M.   Grandi Anna M.  

Publisher： Adis International

ISSN： 1120-9879

Source： High Blood Pressure & Cardiovascular Prevention, Vol.17, Iss.4, 2010-12, pp. : 201-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Matrix Metalloproteinases and Their Tissue Inhibitors in Endocrinology

By Salamonsen L.A.  

Trends in Endocrinology and Metabolism, Vol. 7, Iss. 1, 1996-01 ,pp. : 28-34

Elsevier

Access to resources Recommend Favorite

The Impact of Matrix Metalloproteinases and Their Tissue Inhibitors in Inflammatory Bowel Diseases

By  

Digestive Diseases, Vol. 30, Iss. 3, 2012-06 ,pp. : 289-295

Karger

Access to resources Recommend Favorite

Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer

By Shim Ki-Nam   Jung Sung-Ae   Joo Yang-Hee   Yoo Kwon  

Journal of Gastroenterology, Vol. 42, Iss. 2, 2007-02 ,pp. : 120-128

Springer Publishing Company

Access to resources Recommend Favorite

NADPH oxidases and cardiac remodelling

By Nabeebaccus Adam  

Heart Failure Reviews, Vol. 16, Iss. 1, 2011-01 ,pp. : 5-12

Springer Publishing Company

Access to resources Recommend Favorite

Regional cardiac dysfunction is associated with specific alterations in inflammatory cytokines and matrix metalloproteinases after acute myocardial infarction in sheep

By Gallagher G.  

Basic Research in Cardiology, Vol. 102, Iss. 1, 2007-01 ,pp. : 63-72

Springer Publishing Company

Access to resources Recommend Favorite